埃塞俄比亚的莱什曼病:一个范围审查
Katherine O'Brien1,2, Grace Grifferty2,3, Adriana Totten4
1Department of Public Health and Health Sciences, Northeastern University, Boston, Massachusetts, USA obrien.kather@northeastern.edu.
BMJ open
|June 19, 2025
概括
埃塞俄比亚关于莱什曼病的研究正在增长,但关于预防,控制和卫生系统的研究有限. 需要更多的研究以建立基于证据的治疗策略来对抗这种疾病.
科学领域:
- 热带医学 热带医学
- 公共卫生 公共卫生
- 流行病学 流行病学
背景情况:
- 在东非消除内脏莱什曼病的努力需要了解埃塞俄比亚等流行国家的研究格局.
- 埃塞俄比亚是利什曼病的高负担国家,需要对现有的科学文献进行全面的概述.
研究的目的:
- 为了绘制埃塞俄比亚进行的莱什曼病研究的广度.
- 确定研究缺口和未来科学调查的优先领域.
- 在该地区为消除内脏莱什曼病的战略提供信息.
主要方法:
- 根据JBI和PRISMA-ScR指南进行了范围审查.
- 进行广泛的数据库搜索 (PubMed,Embase,科学网等) 并且进行了注册表检查.
- 数据的提取和综合由两名独立的审核员使用适应埃塞俄比亚环境的详细代码书进行.
主要成果:
- 从8698个已识别的文章中,共包含了639篇关于埃塞俄比亚莱什曼病的论文.
- 在过去的14年里,研究成果稳步增长,涵盖了各种主题.
- 在预防,控制,卫生系统/政策,卡拉阿扎尔后皮肤莱什曼病和随机对照试验的研究中发现了重大差距. 共感染研究占研究的14%.
结论:
- 埃塞俄比亚的莱什曼病研究量正在增加,涉及该疾病的各个方面.
- 需要加强研究,重点关注预防,控制策略和卫生系统/政策.
- 高质量的研究对于支持以证据为基础的治疗和埃塞俄比亚莱什曼病的管理至关重要.
相关概念视频
01:28Fungal Phylum Microsporidia
Microsporidia are a group of obligate intracellular fungi that were initially classified as protists but were later reclassified based on phylogenetic, molecular, and structural evidence linking them to the Chytridiomycota. These unicellular, non-motile organisms are highly specialized parasites that infect a wide range of animal hosts, including humans. They have evolved extensive genomic and metabolic reductions, making them highly dependent on their hosts for survival.Morphology and Genomic...
01:15Anthelminthic Agents
Anthelmintic drugs differ significantly from antiparasitic therapies targeting protozoa, primarily due to differences in parasite biology. Whereas most protozoal treatments act on proliferating cells, anthelmintics are typically directed against mature, nonproliferative helminths. The therapeutic approach considers the helminth's reliance on neuromuscular coordination, glucose metabolism, and microtubular integrity for survival, reproduction, and localization within the host. Most anthelmintics...